Literature DB >> 3729706

Multiple-organ failure and sepsis without bacteria. An experimental model.

R J Goris, W K Boekholtz, I P van Bebber, J K Nuytinck, P H Schillings.   

Abstract

Multiple-organ failure is generally attributed to bacterial infection, although a correlation with positive blood cultures is not consistently found. Consequently, we studied the effects of a local nonbacterial inflammatory stimulus on distant organ functions and metabolism. Wistar rats were inoculated intraperitoneally with zymosan. Heart and ventilatory rates, oxygen consumption, and body temperature were measured. Survivors were killed at day 12 for blood analysis, weighing of organs, and microscopy. Intraperitoneal zymosan resulted in an early hyperdynamic "septic" response with a 35% mortality. After a few days, oxygen consumption decreased, serum lactate levels increased, and the function of multiple organs deteriorated, while blood cultures remained sterile. The experiment was repeated in germ-free rats with similar results but a lower mortality. We concluded that a severe inflammatory response in itself is capable of inducing multiple-organ failure with "sepsis."

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729706     DOI: 10.1001/archsurg.1986.01400080039006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  38 in total

1.  Melanocortins protect against multiple organ dysfunction syndrome in mice.

Authors:  Alessandra Bitto; Francesca Polito; Domenica Altavilla; Natasha Irrera; Daniela Giuliani; Alessandra Ottani; Letteria Minutoli; Luca Spaccapelo; Maria Galantucci; Renzo Lodi; Giuseppe Guzzo; Salvatore Guarini; Francesco Squadrito
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.

Authors:  T J H Volman; R J A Goris; T Hendriks
Journal:  Intensive Care Med       Date:  2005-02-15       Impact factor: 17.440

3.  Lipid peroxidation and lung ultrastructural changes in an experimental model of leukocyte-mediated pulmonary injury.

Authors:  E Borrelli; P Giomarelli; O Chiara; A Casini; S Betti; L Sabatini; L Lorenzini; A Grossi
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.

Authors:  O Mimoz; A Jacolot; C Padoin; J Quillard; M Tod; K Louchahi; K Samii; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 5.  The relationship between gut-derived bacteria and the development of the multiple organ dysfunction syndrome.

Authors:  G A Nieuwenhuijzen; E A Deitch; R J Goris
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

6.  Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction.

Authors:  Yu-Meng Li; Hai-Bin Wang; Jin-Guang Zheng; Xiao-Dong Bai; Zeng-Kai Zhao; Jing-Yuan Li; Sen Hu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

7.  Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice.

Authors:  H W Wang; W Yang; J Y Lu; G Tian; F Li; X H Wang; J R Kang; Y Yang
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

8.  N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model.

Authors:  Hong-Wei Wang; Wen Yang; Jiang-Yang Lu; Fei Li; Jun-Zhong Sun; Wen Zhang; Nan-Nan Guo; Lei Gao; Jia-Rui Kang
Journal:  J Clin Immunol       Date:  2012-12-16       Impact factor: 8.317

Review 9.  Nutrition of the critically ill - emphasis on liver and pancreas.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2012-12       Impact factor: 7.293

10.  Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.

Authors:  Seyhan Sahan-Firat; Meryem Temiz-Resitoglu; Demet Sinem Guden; Sefika Pinar Kucukkavruk; Bahar Tunctan; Ayse Nihal Sari; Zumrut Kocak; Kafait U Malik
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.